Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Foundation Medicine And Clovis Oncology Enter Into Diagnostic Collaboration

RELATED NEWS
Trade CLVS now with 

Foundation Medicine Inc. and Clovis Oncology Inc. (CLVS: Quote) announced that they have entered into a diagnostic collaboration. The company said that the goal of the collaboration is to develop an in-vitro diagnostic or IVD to identify biomarkers to select cancer patients most likely to respond to Clovis' product candidate rucaparib, a poly (ADP-ribose) polymerase or PARP inhibitor currently in Phase I/II clinical development.

Clovis Oncology said that the company and Foundation Medicine will analyze the genomic alterations found in tissue samples from patients to evaluate the feasibility of developing an IVD method to identify patients who have tumors more likely to respond to rucaparib.

In particular, the goal of the collaboration is to identify the additional genetic mutations beyond those in germ-line and somatic BRCA that are associated with defective DNA repair and may define appropriate tumor targets for rucaparib.

Click here to receive FREE breaking news email alerts for Clovis Oncology, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Germany's EU measure of inflation unexpectedly slowed in October after holding steady in the previous two months, preliminary estimates from Destatis showed Thursday. The harmonized index of consumer prices rose 0.7 percent annually following 0.8 percent increase in each of the previous three months.... First-time claims for U.S. unemployment benefits saw a modest increase in the week ended October 25th, according to a report released by the Labor Department on Thursday. The report said initial jobless claims edged up to 287,000, an increase of 3,000 from the previous week's revised level of 284,000. Stocks may move to the downside in early trading on Thursday, adding to the modest losses posted in the previous session. The major index futures are currently pointing to a modestly lower open for the markets, with the Dow futures down by 30 points.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.